001060.KS KSC
JW Pharmaceutical Corporation
1W: -0.4%
1M: -7.8%
3M: +2.9%
YTD: -18.7%
1Y: +20.2%
3Y: -7.7%
5Y: +2.3%
₩26,750.00 ($19.92)
-400.00 (-1.47%)
Weekly Expected Move ±3.1%
₩25116
₩25933
₩26750
₩27567
₩28384
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩617.8B ($460.0M)
52W Range20700-39250
Volume21,175
Avg Volume58,354
Beta0.96
Dividend₩650.00
Analyst Ratings
No analyst coverage
Company Info
CEOYoung-Sub Shin
Employees1,106
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2005-09-29
Websitejw-pharma.co.kr
JW Gwacheon Tower, 38
Gwacheon-si, GY 13840
KR
Gwacheon-si, GY 13840
KR
82 2 840 6777
About JW Pharmaceutical Corporation
JW Pharmaceutical Corporation, established in 1945 and headquartered in Seoul, South Korea, operates globally, focusing on the development, manufacturing, and distribution of a comprehensive range of pharmaceuticals and medical supplies. Its diverse product portfolio addresses numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and metabolic health, as well as infectious diseases, women's health, renal and central nervous system disorders, anti-anemic treatments, respiratory ailments, rheumatic arthritis, oncology, anesthesia, antidotes, and advanced nutritional support.
Latest News
No recent news
Recent Insider Trades
No insider trades found